Literature DB >> 24650427

The seroprevalence of parvovirus B19 infection in pregnant women in Sudan.

O Adam1, T Makkawi1, U Reber2, H Kirberg2, A M Eis-Hübinger2.   

Abstract

Parvovirus B19 (B19V) infection during pregnancy may have serious consequences like fetal anaemia, hydrops fetalis, and fetal loss. Since epidemiological data on B19V infection are generally lacking in Sudan, the current study aimed to determine the seroprevalence of B19V in Sudanese pregnant women. Five hundred women, attending antenatal clinics in Khartoum state between November 2008 and March 2009, were enrolled and screened for B19V IgG and IgM antibodies by enzyme immunoassays. The study revealed a B19V IgG seroprevalence of 61·4%, with one subject positive for IgM. B19V DNA was not detected by PCR in any of the tested individuals. B19V IgG seroprevalence was significantly correlated with multigravidity (P = 0·046). Our data showed that B19V infection is prevalent in Sudan and we recommend further studies in Sudanese women, particularly in those with complications and adverse outcomes of pregnancy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24650427      PMCID: PMC9206789          DOI: 10.1017/S0950268814000600

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  38 in total

1.  Detection of human parvovirus B19 infection in first-trimester fetal loss.

Authors:  Margareta Nyman; Thomas Tolfvenstam; Karin Petersson; Christina Krassny; Lottie Skjöldebrand-Sparre; Kristina Broliden
Journal:  Obstet Gynecol       Date:  2002-05       Impact factor: 7.661

Review 2.  The expanding range of parvoviruses which infect humans.

Authors:  Kevin E Brown
Journal:  Rev Med Virol       Date:  2010-07       Impact factor: 6.989

3.  The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis.

Authors:  N Yaegashi; T Niinuma; H Chisaka; T Watanabe; S Uehara; K Okamura; S Moffatt; K Sugamura; A Yajima
Journal:  J Infect       Date:  1998-07       Impact factor: 6.072

4.  The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world.

Authors:  H A Kelly; D Siebert; R Hammond; J Leydon; P Kiely; W Maskill
Journal:  Epidemiol Infect       Date:  2000-06       Impact factor: 2.451

5.  The burden of parvovirus B19 infection in women of childbearing age in England and Wales.

Authors:  A J Vyse; N J Andrews; L M Hesketh; R Pebody
Journal:  Epidemiol Infect       Date:  2007-02-12       Impact factor: 2.451

6.  Human parvovirus B19 surveillance in patients with rash and fever from Belarus.

Authors:  Marina A Yermalovich; Judith M Hübschen; Galina V Semeiko; Elena O Samoilovich; Claude P Muller
Journal:  J Med Virol       Date:  2012-06       Impact factor: 2.327

7.  Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection.

Authors:  J Mossong; N Hens; V Friederichs; I Davidkin; M Broman; B Litwinska; J Siennicka; A Trzcinska; P VAN Damme; P Beutels; A Vyse; Z Shkedy; M Aerts; M Massari; G Gabutti
Journal:  Epidemiol Infect       Date:  2007-10-24       Impact factor: 2.451

8.  Long-term parvovirus B19 viraemia associated with pure red cell aplasia after allogeneic bone marrow transplantation.

Authors:  Annelie Plentz; Joachim Hahn; Ernst Holler; Wolfgang Jilg; Susanne Modrow
Journal:  J Clin Virol       Date:  2004-09       Impact factor: 3.168

9.  Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops.

Authors:  Martin Enders; Andrea Weidner; Tessa Rosenthal; Carola Baisch; Lea Hedman; Maria Söderlund-Venermo; Klaus Hedman
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

10.  Seroprevalence of parvovirus B19 in the German population.

Authors:  C Röhrer; B Gärtner; A Sauerbrei; S Böhm; B Hottenträger; U Raab; W Thierfelder; P Wutzler; S Modrow
Journal:  Epidemiol Infect       Date:  2008-01-16       Impact factor: 2.451

View more
  3 in total

Review 1.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Molecular Evaluation of Human Parvovirus B19 Infection and Associated Risk Factors among Pregnant Women in Bushehr Province, Southern Iran.

Authors:  Reza Taherkhani; Fatemeh Farshadpour; Masomeh Norozi
Journal:  Am J Trop Med Hyg       Date:  2022-03-07       Impact factor: 3.707

3.  Seroprevalence of erythrovirus B19 in Saudi pregnant women.

Authors:  Ayman K Johargy
Journal:  J Family Community Med       Date:  2016 May-Aug
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.